EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Opportunities for artificial intelligence and synthetic biology in designing living drug delivery systems

Jason H Yang, Caleb J Bashor

Advanced Drug Delivery Reviews · 2026-08 · 235 · 115883

DOI: 10.1016/j.addr.2026.115883 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Drug Delivery Reviews, 2026-08. Verfasst von Jason H Yang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Center for Emerging and Re-emerging Pathogens, Rutgers New Jersey Medical School, Newark, NJ 07103, USA; Department of Microbiology, Biochemistry, an…. Hauptthemen laut MEDLINE: Synthetic Biology, Drug Delivery Systems, Artificial Intelligence. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 301 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIBIB NIH HHS, National Institute of Allergy and Infectious Diseases Division of Intramural Research, Office of Naval Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Advances in artificial intelligence (AI) and synthetic biology are transforming biological research and biotechnology. These fields are for the first time enabling the design and development of human and bacterial cells that can serve as "living" drug delivery vehicles that perform sustained release of therapeutic cargo with spatiotemporal control. In recent years, human and bacterial cells have been engineered to deliver peptides, proteins, and biologics for treating a wide range of human diseases using synthetic biology approaches. To engineer effective living drug delivery systems, detailed knowledge is required about how to design receptors that can specifically sense the tissues targeted for drug delivery, signaling networks that can process signals from these receptors, and gene circuits that can control therapeutic cargo production and release. However, elucidating such receptors, signal processing and gene regulatory elements, and gene circuit compositions by traditional design-build-test-learn approaches is difficult and low throughput. Here we review how advances in AI and synthetic biology are meeting these challenges. We describe examples of how human cells and bacteria are engineered to become living drug delivery vehicles. We discuss how AI and synthetic biology approaches are being applied to discover the sequence-to-function design principles for engineering synthetic receptors, signaling proteins, and gene regulatory elements and the composition-to-function design principles for engineering synthetic gene circuits. We share an outlook on opportunities for AI and synthetic biology to synergize for creating next-generation living drug delivery systems.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Synthetic BiologyDrug Delivery SystemsArtificial IntelligenceHumansAnimals

Stichwörter der Autor:innen

Artificial intelligenceComposition-to-functionLiving drug deliveryMassively parallel reporter assaysStructure-to-functionSynthetic biology

Autor:innen und Institutionen

  • Center for Emerging and Re-emerging Pathogens, Rutgers New Jersey Medical School, Newark, NJ 07103, USA; Department of Microbiology, Biochemistry, and Molecular Genetics, Rutgers New Jersey Medical School, Newark, NJ 07…
  • Department of Bioengineering, Rice University, Houston, TX 77005, USA; Department of Biosciences, Rice University, Houston, TX 77005, USA; Rice Synthetic Biology Institute, Rice University, Houston, TX 77005, USA; Ken K…

Förderung

  • NIBIB NIH HHS
  • National Institute of Allergy and Infectious Diseases Division of Intramural Research
  • Office of Naval Research
  • Robert J Kleberg Jr & Helen C Kleberg Foundation
  • Agilent Technologies Inc
  • National Institute of Biomedical Imaging and Bioengineering
  • Rutgers The State University of New Jersey
  • National Institutes of Health

Zitieren

APA

Yang, J. H., & Bashor, C. J. (2026). Opportunities for artificial intelligence and synthetic biology in designing living drug delivery systems. Advanced Drug Delivery Reviews, 235, 115883. https://doi.org/10.1016/j.addr.2026.115883

Vancouver

Yang JH, Bashor CJ. Opportunities for artificial intelligence and synthetic biology in designing living drug delivery systems. Advanced Drug Delivery Reviews. 2026;235:115883. doi:10.1016/j.addr.2026.115883

BibTeX
@article{Yang2026,
  author = {Yang, Jason H and Bashor, Caleb J},
  title = {Opportunities for artificial intelligence and synthetic biology in designing living drug delivery systems},
  journal = {Advanced Drug Delivery Reviews},
  year = {2026},
  volume = {235},
  pages = {115883},
  doi = {10.1016/j.addr.2026.115883}
}
Kostenlos starten →